GoHealth (GOCO) Cash & Equivalents (2019 - 2026)

GoHealth's Cash & Equivalents history runs 8 years deep, the most recent figure standing at $39.9 million for Q1 2026.

• In Q1 2026, Cash & Equivalents rose 80.02% year-over-year to $39.9 million; the TTM figure through Mar 2026 stood at $39.9 million (up 80.02% YoY), while the FY2025 annual figure was $32.9 million, down 19.59% from the prior year.
• Cash & Equivalents came in at $39.9 million for Q1 2026 at GoHealth, up from $32.9 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $215.4 million in Q3 2022 to a low of $14.1 million in Q2 2024.
• A 5-year average of $56.7 million and a median of $35.5 million in 2024 frame the typical range for Cash & Equivalents.
• On a YoY basis, Cash & Equivalents climbed as much as 451.56% in 2023 and fell as far as 87.75% in 2023.
• GoHealth's Cash & Equivalents stood at $16.5 million in 2022, then soared by 451.56% to $90.8 million in 2023, then plunged by 54.94% to $40.9 million in 2024, then slipped by 19.59% to $32.9 million in 2025, then grew by 21.2% to $39.9 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $39.9 million, $32.9 million, and $32.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison